Related Experiment Video
Updated: Sep 13, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Migration and
Paul L Deford1, Andrew P VonHandorf2, Brian G Hunt3
1Kettering Laboratory, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, 160 Panzeca Way, Cincinnati, OH 45267-0056, USA.
Targeting Stathmin 1 (STMN1) phosphorylation, specifically at S16, shows promise in inhibiting MET-driven cancer cell growth. This approach may offer a new strategy for treating metastatic cancers and preventing their spread.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastatic cancer treatment faces challenges due to acquired therapy resistance.
- Stathmin 1 (STMN1) plays a critical role in cancer cell growth and metastasis.
- Understanding STMN1's function is key to developing novel cancer therapies.
Purpose of the Study:
- To analyze the role of STMN1 in regulating cancer cell growth and metastatic potential.
- To investigate the interrelationship between STMN1, HGF, and MET in metastatic cancers.
- To determine the impact of STMN1 phosphorylation on cancer cell proliferation and metastasis.
Main Methods:
- Analysis of public datasets for metastatic castration-resistant prostate cancer (mCRPC) and breast cancer (BC).
- Assays including site-directed mutagenesis, cell cycle analysis, proliferation, migration, and invasion.
- Investigated STMN1 phosphorylation at serine residues (S16, S25, S38, S63).
Main Results:
- Increased STMN1 correlates with HGF and MET expression in mCRPC; taxane chemotherapy elevates HGF.
- STMN1 and HGF levels are highest in liver metastases, associated with poorer survival.
- Phosphorylation of STMN1 at S16 (pSTMN1^S16) promotes cell proliferation and shortens cell cycle, while dephosphorylation arrests growth.
- pSTMN1^S16 does not enhance metastasis.
Conclusions:
- Selective inhibition of STMN1^S16 phosphorylation is a potential strategy against MET-mediated cancer cell growth.
- This approach could help eliminate metastatic cancer cells and prevent further spread.
- Targeting STMN1 phosphorylation offers a novel therapeutic avenue for metastatic cancers.
Related Concept Videos
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
Destabilization of Microtubules
Positive Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...

